Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Colonic Neoplasms × Imatinib Mesylate × Clear all

Phase

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22 Leukemia 13 Leukemia, Myeloid, Chronic-Phase 11 Gastrointestinal Stromal Tumors 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Myeloproliferative Disorders 4 Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Myeloid 3 Blast Crisis 3 Thyroid Neoplasms 2 Prostatic Neoplasms 2 Primary Myelofibrosis 2 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hematologic Neoplasms 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Brain Neoplasms 2 Bone Marrow Diseases 2 Uterine Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Thrombocytosis 1 Thrombocythemia, Essential 1

Interventions

Oxaliplatin 23 Irinotecan 23 Fluorouracil 23 Leucovorin 21 Bevacizumab 21 Capecitabine 17 Cetuximab 13 Radiotherapy 5 Immunohistochemistry 4 Folfox protocol 4 Colonoscopy 4 Mitomycin 3 Gene Expression Profiling 3 Gemcitabine 3 Doxorubicin 3 Cisplatin 3 Cholecalciferol 3 Aspirin 3 Amplified Fragment Length Polymorphism Analysis 3 ixabepilone 2 cediranib 2 adagrasib 2 Tea 2 Surveys and Questionnaires 2 Sulindac 2 Stents 2 Reverse Transcriptase Polymerase Chain Reaction 2 Receptor Protein-Tyrosine Kinases 2 Radiofrequency Ablation 2 Radiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02685046 2019-10-14

ImPACCT

UMC Utrecht

Phase 2 Terminated

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡